BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34429421)

  • 1. Cas9-derived peptides presented by MHC Class II that elicit proliferation of CD4
    Simhadri VL; Hopkins L; McGill JR; Duke BR; Mukherjee S; Zhang K; Sauna ZE
    Nat Commun; 2021 Aug; 12(1):5090. PubMed ID: 34429421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4
    Xiao Q; Chen S; Wang Q; Liu Z; Liu S; Deng H; Hou W; Wu D; Xiong Y; Li J; Guo D
    Retrovirology; 2019 Jun; 16(1):15. PubMed ID: 31186067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of Pre-Existing Adaptive Immune Responses Against SaCas9 in Humans Using Epitope Mapping and Identification.
    Shen X; Lin Q; Liang Z; Wang J; Yang X; Liang Y; Liang H; Pan H; Yang J; Zhu Y; Li M; Xiang W; Zhu H
    CRISPR J; 2022 Jun; 5(3):445-456. PubMed ID: 35686980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection.
    Wang Q; Chen S; Xiao Q; Liu Z; Liu S; Hou P; Zhou L; Hou W; Ho W; Li C; Wu L; Guo D
    Retrovirology; 2017 Nov; 14(1):51. PubMed ID: 29141633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC-associated peptide proteomics enabling highly sensitive detection of immunogenic sequences for the development of therapeutic antibodies with low immunogenicity.
    Sekiguchi N; Kubo C; Takahashi A; Muraoka K; Takeiri A; Ito S; Yano M; Mimoto F; Maeda A; Iwayanagi Y; Wakabayashi T; Takata S; Murao N; Chiba S; Ishigai M
    MAbs; 2018; 10(8):1168-1181. PubMed ID: 30199322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo.
    Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R
    J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9.
    Feng Y; Chen C; Han Y; Chen Z; Lu X; Liang F; Li S; Qin W; Lin S
    G3 (Bethesda); 2016 Aug; 6(8):2517-21. PubMed ID: 27317783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationally engineered
    Tan Y; Chu AHY; Bao S; Hoang DA; Kebede FT; Xiong W; Ji M; Shi J; Zheng Z
    Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20969-20976. PubMed ID: 31570596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
    Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
    Front Immunol; 2018; 9():1795. PubMed ID: 30127785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation.
    Gregers TF; Fleckenstein B; Vartdal F; Roepstorff P; Bakke O; Sandlie I
    Int Immunol; 2003 Nov; 15(11):1291-9. PubMed ID: 14565927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.
    Singh R; Singh S; Sharma PK; Singh UP; Briles DE; Hollingshead SK; Lillard JW
    PLoS One; 2010 Feb; 5(2):e9432. PubMed ID: 20195541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications.
    Afridi S; Hoessli DC; Hameed MW
    Immunol Rev; 2016 Jul; 272(1):151-68. PubMed ID: 27319349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Split Staphylococcus aureus Cas9 as a Compact Genome-Editing Tool in Plants.
    Kaya H; Ishibashi K; Toki S
    Plant Cell Physiol; 2017 Apr; 58(4):643-649. PubMed ID: 28371831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling MHC II immunopeptidome of blood-stage malaria reveals that cDC1 control the functionality of parasite-specific CD4 T cells.
    Draheim M; Wlodarczyk MF; Crozat K; Saliou JM; Alayi TD; Tomavo S; Hassan A; Salvioni A; Demarta-Gatsi C; Sidney J; Sette A; Dalod M; Berry A; Silvie O; Blanchard N
    EMBO Mol Med; 2017 Nov; 9(11):1605-1621. PubMed ID: 28935714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules.
    Appella E; Padlan EA; Hunt DF
    EXS; 1995; 73():105-19. PubMed ID: 7579970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
    Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Human Genome Editing Using SaCas9 Ribonucleoprotein Complexes.
    Wang Y; Wang B; Xie H; Ren Q; Liu X; Li F; Lv X; He X; Cheng C; Deng R; Li J; Zhao J; Song Z; Gu F
    Biotechnol J; 2019 Jul; 14(7):e1800689. PubMed ID: 30927491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
    Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N
    Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of MHC-Bound Peptides from Dendritic Cells Infected with Salmonella enterica Strain SL1344: Implications for a Nontyphoidal Salmonella Vaccine.
    Karunakaran KP; Yu H; Jiang X; Chan Q; Goldberg MF; Jenkins MK; Foster LJ; Brunham RC
    J Proteome Res; 2017 Jan; 16(1):298-306. PubMed ID: 27802388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.